Emerging Leader Award

Grant Name
Emerging Leader Award
Funder
Bay Area Lyme Foundation
Country or Region
United States
Research Field
Bacterial Infections
Infectious Diseases
Lyme Disease
Deadline
February 15, 2022 (Expired)
Grant Size
Upper $250,000USD Lower $100,000USD 12–18 months for $100,000 award or 18-24 months for $250,000 award.
Contact Info
Bay Area Lyme Foundation info@bayarealyme.org
Eligibility
Affiliated with an academic or research institution in the U.S. or corporate equivalent Demonstrated professional and scientific leadership in biological and medical sciences Exhibited scientific curiosity and an established pattern of creative thinking A defined approach to improved diagnostics or therapies for Lyme disease The $250,000 ELA grant targets veteran scientific talent with the title of associate professor or above. Applicants must be at a US academic institution or corporate equivalent and propose to apply their work in other fields to therapeutics or diagnostics in Lyme disease. The $100,000 ELA grant is offered to researchers in academia or the private sector who are currently at the post-doctoral level through assistant professor level or equivalent. Those who have not previously worked in Lyme disease research are also encouraged to apply.
Description
The Bay Area Lyme Foundation Emerging Leader Awards (ELA) recognize both established and up-and-coming researchers bringing new approaches and creative thinking to the field of Lyme disease. These grants support new and innovative projects and aim to attract aspiring new scientific talent to the field of Lyme. Candidate applications must include a viable proposal for a proof-of-concept project to be funded, in part or in sum, by the grant award. Eligibility Affiliated with an academic or research institution in the U.S. or corporate equivalent Demonstrated professional and scientific leadership in biological and medical sciences Exhibited scientific curiosity and an established pattern of creative thinking A defined approach to improved diagnostics or therapies for Lyme disease The $250,000 ELA grant targets veteran scientific talent with the title of associate professor or above. Applicants must be at a US academic institution or corporate equivalent and propose to apply their work in other fields to therapeutics or diagnostics in Lyme disease. The $100,000 ELA grant is offered to researchers in academia or the private sector who are currently at the post-doctoral level through assistant professor level or equivalent. Those who have not previously worked in Lyme disease research are also encouraged to apply.

Funding resources

Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share


Add deadline to calendar

February 15, 2022

Have a funding opportunity that you want to list here?

Submit the grant details to support@peeref.com for review and listing.


Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Related opportunities

Australian National Aged Care Classification (AN-ACC) Transition Fund
Aged Care 30-Jun-2024 $55,440,000.00
Northern Territory Pathways to Community Control
Indigenous Health 30-Jun-2024 $8,750,000.00
Leading Engineering for America's Prosperity, Health, and Infrastructure
Science and Technology and other Researc... Sep 16, 2024 12:00:00 AM EDT $2,000,000
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
Health May 28, 2025 12:00:00 AM EDT $1,500,000
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale)
Medicine September 30, 2025 Up to 25,000,000 USD
MOMENTUM (Moving integrated, quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health services to scale): MOMENTUM Monitoring and evaluation, knowledge management and translation
Medicine September 30, 2025 Up to 25,000,000 USD
Innovative Health Practices
Science and Technology and other Researc... Feb 20, 2028 12:00:00 AM EST $1,000,000,000